Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages

Cytokine

Volumn 44, Issue 3, 2008, Pages 386-391

  Lkhagvaa, Battur ^a   Tani, Kenji ^a   Sato, Keiko ^a   Toyoda, Yuko ^a   Suzuka, Chiyuki ^a   Sone, Saburo ^a  

^a Institute of Health Biosciences   (Japan)

Author keywords

Aminopeptidase; Bestatin; Cytokine; Monocytes; Sarcoidosis

Indexed keywords

AMINOPEPTIDASE; BESTATIN; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOIDOSIS;

AMINOPEPTIDASES; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; LEUCINE; LIPOPOLYSACCHARIDES; MACROPHAGES; MONOCYTES; PROTEASE INHIBITORS; RNA, MESSENGER;

EID: 57449101615     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.10.011     Document Type: Article

References (49)

1. Look A.T., Ashmun R.A., Shapiro L.H., and Peiper S.C. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 83 (1989) 1299-1307
2. Antczak C., De Meester I., and Bauvois B. Ectopeptidases in pathophysiology. Bioessays 23 (2001) 251-260
3. Shipp M.A., and Look A.T. Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key!. Blood 82 (1993) 1052-1070
4. Sanderink G.J., Artur Y., and Siest G. Human aminopeptidases: a review of the literature. J Clin Chem Clin Biochem 26 (1988) 795-807
5. Harris C.A., Hunte B., Krauss M.R., Taylor A., and Epstein L.B. Induction of leucine aminopeptidase by interferon-gamma. J Biol Chem 267 (1992) 6865-6869
6. Turek J.J., and Robinson J.P. Leucine aminopeptidase activity by flow cytometry. Methods Cell Biol 41 (1994) 461-467
7. Raynaud F., Bauvouis B., Gerbaud P., and Evain-Brion D. Characterization of specific proteases associated with the surface of human skin fibroblasts, and their modulation in pathology. J Cell Physiol 151 (1992) 378-385
8. Piela-Smith T.H., and Korn J.H. Aminopeptidase N: a constitutive cell-surface protein on human dermal fibroblasts. Cell Immunol 162 (1995) 42-48
9. Saiki I., Fujii H., Yoneda J., Abe F., Nakajima M., and Tsuruo T. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54 (1993) 137-143
10. Ino K., Goto S., Okamoto T., Nomura S., Nawa A., and Isobe K. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity. Jpn J Cancer Res 85 (1994) 927-933
11. Tani K., Ogushi F., Huang L., Kawano T., Tada H., and Sone S. CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis. Am J Respir Crit Care Med 161 (2000) 1636-1642
12. Umezawa H., Aoyagi T., Suda H., Hamada M., and Takeuchi T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot (Tokyo) 29 1 (1976) 97-99
13. Suda H., Takita T., Aoyagi T., and Umezawa H. The structure of bestatin. J Antibiot (Tokyo) 29 (1976) 100-101
14. Rich D.H., Moon B.J., and Harbeson S. Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J Med Chem 27 (1984) 417-422
15. Grembecka J., Mucha A., Cierpicki T., and Kafarski P. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity. J Med Chem 46 (2003) 2641-2655
16. Koya T., Narita J., Honda S., and Ano T. Immunomodulation induced by Ubenimex, an antibiotic inhibitor of aminopeptidase. Biomed Res (Tokyo) 20 (1999) 161-167
17. Abe F., Shibuya K., Uchida M., Takahashi K., Horinishi H., Matsuda A., et al. Effect of bestatin on syngeneic tumors in mice. Gann 75 (1984) 89-94
18. Yamazaki T., Sugiyama K., and Ichihara K. Effect of ubenimex on the immune system of patients with hematological malignancies. Biomed Pharmacother 45 (1991) 105-112
19. Yamagishi H., Naito K., Ueda Y., Itoi S., Kohnosu H., Kobayashi M., et al. Bestatin administration and the change in cellular immunity. Biomed Pharmacother 45 (1991) 117-120
20. Ota K., Kurita S., Yamada K., Masaoka T., Uzuka Y., and Ogawa N. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults. Cancer Immunol Immunother 23 (1986) 5-10
21. Ota K., and Ogawa N. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults. Biomed Pharmacother 44 (1990) 93-101
22. Urabe A., Mutoh Y., Mizoguchi H., Takaku F., and Ogawa N. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults. Ann Hematol 67 (1993) 63-66
23. Tsunogake S., Takano N., Enokihara H., and Furusawa S. Differential effects of ubenimex on growth of normal human haematopoietic progenitors and leukaemic cells in vitro. Int J Immunother 7 (1991) 63-72
24. Minshall E.M., Tsicopoulos A., Yarsuel Z., Wallaert B., Akoum H., Vorng H., et al. Cytokine mRNA gene expression in active and nonactive pulmonary sarcoidosis. Eur Respir J 10 (1997) 2034-2039
25. Feldmann M., Brennan F.M., and Maini R.N. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14 (1996) 397-440
26. Ye Q., Chen B., Tong Z., Nakamura S., Sarria R., Costabel U., et al. Thalidomide reduces IL-18, IL-8 and TNF-alpha release from alveolar macrophages in interstitial lung disease. Eur Respir J 28 (2006) 824-831
27. Thomas P.D., and Hunninghake G.W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 135 (1978) 747-760
28. Sibille Y., and Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respor Dis 141 (1990) 471-501
29. Hirano T., Matsuda T., Turner M., Miyasaka N., Buchan G., Tang B., et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18 (1988) 1797-1801
30. Linker-Israeli M., Deans R.J., Wallace D.J., Prehn J., Ozeri-Chen T., and Klinenberg J.R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 147 (1991) 117-123
31. Horii Y., Muraguchi A., lwano M., Matsuda T., Hirayama T., Yamada H., et al. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143 (1989) 3949
32. Seitz M., Dewald B., Gerber N., and Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 rheumatoid arthritis. J Clin Invest 87 (1991) 463-467
33. Hack C.E., Hart M., van Schijndel R.J., Eerenberg A.J., Nuijens J.H., Thijs L.G., et al. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect Immun 60 (1992) 2835-2842
34. Richman-Eisent J.B., Jorens P.G., Hebert C.A., Ueki I., and Nadel J.A. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Respir Cell Mol Biol 264 (1993) L413-L418
35. Davatelis G., Tekamp-Olson P., Wolpe S.D., Hermsen K., Leudke C., Gallegos C., et al. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med 167 (1988) 1939-1944
36. de Vries J.E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27 (1995) 537-541
37. de Waal Malefyt R., Abrams R.J., Bennett B., et al. Interleukin (IL)-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174 (1991) 1209-1220
38. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-19765
39. Kopydlowski K.M., Salkowski C.A., Cody M.J., van Rooijen N., et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 163 (1999) 1537-1544
40. Mosmann T.R. Properties and functions of interleukin-10. Adv Immunol 56 (1994) 1-26
41. Thomas P.D., and Hunninghake G.W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 135 (1987) 747-760
42. Sibille Y., and Reynolds H.Y. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141 (1990) 471-501
43. Tsunogake S., Furusawa S., Nagashima S., Nakamura Y., Enokihara H., Shishido H., et al. Effect of aminopeptidase inhibitors on the production of various cytokines by peripheral blood mononuclear cells and stromal cells and on stem cell factor gene expression in stromal cells: comparison of ubenimex with its stereoisomers. Int J Immunotherapy 10 (1994) 41-47
44. Shibuya K., Hayashi E., Abe F., Takahashi K., Horinishi H., Ishizuka M., et al. Enhancement of interleukin-1 and interleukin-2 releases by ubenimex. J Antibiotics 40 (1987) 363
45. Kanayama N., Kajiwara Y., Goto J., el Maradny E., Maehara K., et al. Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 57 (1995) 129-134
46. Scornik O.A., and Botbol V. Bestatin as an experimental tool in mammals. Curr Drug Metab 2 (2001) 67-85
47. Dan H., Tani K., Hase K., Ogawa H., Huang L., Shinomiya F., et al. CD13/aminopeptidase N in collagen vascular diseases. Rheumatol Int 23 (2002) 271-276
48. Shimizu T., Tani K., Hase K., Ogawa H., Huang L., Shinomiya F., et al. CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum 46 (2002) 2330-2338
49. Favaloro E.J., Browning T., and Facey D. CD13 (GP150; aminopeptidase-N): predominant functional activity in blood is localized to plasma and is not cell-surface associated. Exp Hematol 21 (1993) 1695-1701